Detalhe da pesquisa
1.
Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis.
Br J Dermatol
; 189(4): 368-380, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37410552
2.
Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohort.
BMJ Open
; 12(9): e059979, 2022 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36130766